Table 3.

Patient-reported outcomes assessed at baseline, 1 month, and 6 months

Patient Outcome Measures	Baseline (N=280)				P- value	1 month (N=253)				P- value	6 months (N=246)				P- value
	Intervention		Control			Intervention		Control			Intervention		Control
	(N=139)		(N=141)			(N=120)		(N=133)			(N=115)		(N=131)
Primary Endpoint
Chemoprevention uptake, N (%)											3	2.1%	5	3.5%	0.735
Decision Antecedents
Breast cancer risk perception
Accurate breast cancer risk perception, N (%)	51	38%	43	32%	0.332	64	56%	50	39%	0.017	44	39%	45	36%	0.785
Underestimate, N (%)	17	13%	25	19%		9	8%	21	16%		14	13%	19	15%
Overestimate, N (%)	67	50%	67	50%		42	37%	57	45%		54	48%	61	49%
Breast cancer worry, mean (SD) [range, 1-7]	3.18 (1.56)		3.04 (1.36)		0.447	3.10 (1.63)		3.30 (1.66)		0.295	3.08 (1.51)		3.04 (1.28)		0.841
Self-efficacy, mean (SD) [range, 0-100]	82.73 (17.51)		83.00 (18.42)		0.797	84.01 (18.63)		83.05 (19.80)		0.864
Chemoprevention knowledge
Adequate knowledge, N (%)	26	19%	24	17%	0.713	58	49%	36	27%	<.001	43	37%	44	34%
Decision Quality
Decision conflict, mean (SD) [range, 0-100]						33.97 (27.59)		47.03 (27.76)		<.001	34.38 (27.54)		41.16 (30.40)		0.072
Chemoprevention attitudes, N (%)
Positive						16	14%	20	15%	0.953	14	12%	18	14%	0.445
Neutral						38	33%	44	33%		21	18%	31	24%
Negative						62	53%	69	52%		79	69%	79	62%
Chemoprevention intention, N (%)
Likely						21	18%	31	23%	0.282
Not Likely						97	82%	102	77%
Informed Choice, N (%)						48	41%	31	23%	0.003	39	34%	36	28%	0.333